Bayer Forms Sales Partnership With Schering-Plough
693054
Bayer AG, Germany&#39;s second-biggest drug and chemical maker, formed a partnership with US rival Schering-Plough Corp. to market some of Bayer&#39;s biggest medicines after sales lagged in the second quarter.
384787
+16% dopo vendita Organon al gruppo Usa Schering-Plough
533746
German stocks advanced, led by Bayer AG, after the company said it formed a marketing partnership with a US competitor. The benchmark DAX Index rose 30.
230439
LONDON (CBS.MW) -- European drugmakers Novartis, Schering and Sanofi-Aventis on Thursday all posted rising third-quarter sales, helped by sales lifts in the companies&#39; key products.
65941
German chemicals and pharmaceutcials giant Bayer said Wednesday that it planned to axe 950 jobs in Berlin following its acquisition of drug-maker Schering, which is based in the German capital.
261394
The US division of Germany's Bayer AG agreed to pay a 33 million dollar fine to settle charges it participated in a conspiracy to fix prices of a commonly used chemical for plastics and other goods, US officials said.
595740
Schering-Plough Corp. swung to a profit in the third quarter from a loss a year ago, even as sales decline slightly in the period.
607189
The Bayer Corporation, a subsidiary of the Bayer Group of Germany, has agreed to plead guilty and pay a $33 million criminal fine for taking part in a conspiracy
501320
German chemicals and pharmaceuticals giant Bayer said that it has agreed to sell its metals subsidiary HC Starck to private equity firms Advent and Carlyle for about 1.2 billion euros (1.6 billion dollars) in total.
71950
Schering-Plough Corp  has agreed to buy Akzo Nobel NV's  drugs unit Organon BioSciences for 11 billion euros ($14.4 billion) in a bid to gain scale and diversify away from cholesterol medicine.
583937
BAYER has formed an alliance for its struggling pharmaceuticals business with American drug-maker Schering-Plough. Drugs and chemicals group Bayer, which is in the midst of restructuring its business, said
318406
Germany&#039;s Bayer AG  fell  short of the 95 percent stake it needs to start a squeeze out  of minority shareholders in drugmaker Schering AG, but still  plans to buy the rest of the shares, it said on Wednesday.
75799
Schering-Plough and Merck posted strong sales from their joint venture in cholesterol drugs, but otherwise their third-quarter earnings were notably different.
439835
The Schering-Plough Corp. will market and distribute Bayer AG&#39;s primary care pharmaceutical products in the United States under an agreement announced Monday that could impact up to 1,800 jobs.
750251
BOSTON (CBS.MW) -- Pharmaceutical conglomerates Schering-Plough and Bayer have entered into a broad joint-marketing deal Monday for several of the companies&#39; leading drugs.
217896
FRANKFURT Bayer said Monday that it had formed a partnership with Schering-Plough to market some of its biggest drugs in the United States.
419077
LONDON (CBS.MW) -- Bayer AG (DE:575200) (BAY) Monday said it has agreed to sell its plasma products business to NPS BioTherapeutics, Inc.